243 related articles for article (PubMed ID: 17417131)
21. Altered cerebrovascular responses after exposure to venoarterial extracorporeal membrane oxygenation: role of the nitric oxide pathway.
Ingyinn M; Rais-Bahrami K; Viswanathan M; Short BL
Pediatr Crit Care Med; 2006 Jul; 7(4):368-73. PubMed ID: 16738508
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States.
Angus DC; Clermont G; Watson RS; Linde-Zwirble WT; Clark RH; Roberts MS
Pediatrics; 2003 Dec; 112(6 Pt 1):1351-60. PubMed ID: 14654609
[TBL] [Abstract][Full Text] [Related]
23. Inhaled nitric oxide therapy during the transport of neonates with persistent pulmonary hypertension or severe hypoxic respiratory failure.
Lowe CG; Trautwein JG
Eur J Pediatr; 2007 Oct; 166(10):1025-31. PubMed ID: 17205243
[TBL] [Abstract][Full Text] [Related]
24. Hypoxic respiratory failure: etiology and outcomes at one referral center 2000 through 2005.
Truog WE; Kurth G; Haney B; Kilbride HW
J Perinatol; 2007 Jun; 27(6):371-4. PubMed ID: 17443197
[TBL] [Abstract][Full Text] [Related]
25. The use of dipyridamole to wean from inhaled nitric oxide in congenital diaphragmatic hernia.
Buysse C; Fonteyne C; Dessy H; De Laet MH; Biarent D
J Pediatr Surg; 2001 Dec; 36(12):1864-5. PubMed ID: 11733927
[TBL] [Abstract][Full Text] [Related]
26. A 22-year experience in global transport extracorporeal membrane oxygenation.
Coppola CP; Tyree M; Larry K; DiGeronimo R
J Pediatr Surg; 2008 Jan; 43(1):46-52; discussion 52. PubMed ID: 18206454
[TBL] [Abstract][Full Text] [Related]
27. Do we need new indications for ECMO in neonates pretreated with high-frequency ventilation and/or inhaled nitric oxide?
Kössel H; Bauer K; Kewitz G; Karaca S; Versmold H
Intensive Care Med; 2000 Oct; 26(10):1489-95. PubMed ID: 11126261
[TBL] [Abstract][Full Text] [Related]
28. Comparison of methods for intravenous infusion of fat emulsion during extracorporeal membrane oxygenation.
Buck ML; Wooldridge P; Ksenich RA
Pharmacotherapy; 2005 Nov; 25(11):1536-40. PubMed ID: 16232016
[TBL] [Abstract][Full Text] [Related]
29. The outcome in newborns with congenital diaphragmatic hernia in a Norwegian region.
Fredly S; Aksnes G; Viddal KO; Lindemann R; Fugelseth D
Acta Paediatr; 2009 Jan; 98(1):107-11. PubMed ID: 18795908
[TBL] [Abstract][Full Text] [Related]
30. Extracorporeal membrane oxygenation for cardiopulmonary failure in pediatric patients: is a second course justified?
Fisher JC; Stolar CJ; Cowles RA
J Surg Res; 2008 Jul; 148(1):100-8. PubMed ID: 18570938
[TBL] [Abstract][Full Text] [Related]
31. Persistent Pulmonary Hypertension of the Newborn with D-transposition of the Great Arteries: Management and Prognosis.
Sallaam S; Natarajan G; Aggarwal S
Congenit Heart Dis; 2016 May; 11(3):239-44. PubMed ID: 26554402
[TBL] [Abstract][Full Text] [Related]
32. Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn.
Hoffman GM; Ross GA; Day SE; Rice TB; Nelin LD
Crit Care Med; 1997 Feb; 25(2):352-9. PubMed ID: 9034276
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and economy of inhaled nitric oxide in neonates accepted for extra-corporeal membrane oxygenation.
Lönnqvist PA
Acta Physiol Scand; 1999 Oct; 167(2):175-9. PubMed ID: 10571554
[TBL] [Abstract][Full Text] [Related]
34. Inhaled nitric oxide in the management of preterm infants with severe respiratory failure.
Su PH; Chen JY
J Perinatol; 2008 Feb; 28(2):112-6. PubMed ID: 17989696
[TBL] [Abstract][Full Text] [Related]
35. Continuous venovenous hemofiltration with or without extracorporeal membrane oxygenation in children.
Shaheen IS; Harvey B; Watson AR; Pandya HC; Mayer A; Thomas D
Pediatr Crit Care Med; 2007 Jul; 8(4):362-5. PubMed ID: 17545928
[TBL] [Abstract][Full Text] [Related]
36. Medical and financial impact of a neonatal extracorporeal membrane oxygenation referral center in the nitric oxide era.
Pawlik TD; Porta NF; Steinhorn RH; Ogata E; deRegnier RA
Pediatrics; 2009 Jan; 123(1):e17-24. PubMed ID: 19064612
[TBL] [Abstract][Full Text] [Related]
37. Intravenous prostacyclin mitigates inhaled nitric oxide rebound effect: A case control study.
Hermon M; Golej J; Burda G; Marx M; Trittenwein G; Pollak A
Artif Organs; 1999 Nov; 23(11):975-8. PubMed ID: 10564300
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide and milrinone: combined effect on pulmonary circulation after Fontan-type procedure: a prospective, randomized study.
Cai J; Su Z; Shi Z; Zhou Y; Xu Z; Xu Z; Yang Y
Ann Thorac Surg; 2008 Sep; 86(3):882-8; discussion 882-8. PubMed ID: 18721577
[TBL] [Abstract][Full Text] [Related]
39. Automated inhaled nitric oxide alerts for adult extracorporeal membrane oxygenation patient identification.
Belenkiy SM; Batchinsky AI; Park TS; Luellen DE; Serio-Melvin ML; Cancio LC; Pamplin JC; Chung KK; Salinas J; Cannon JW
J Trauma Acute Care Surg; 2014 Sep; 77(3 Suppl 2):S184-9. PubMed ID: 25159353
[TBL] [Abstract][Full Text] [Related]
40. Aerosolized PGE1: a selective pulmonary vasodilator in neonatal hypoxemic respiratory failure results of a Phase I/II open label clinical trial.
Sood BG; Delaney-Black V; Aranda JV; Shankaran S
Pediatr Res; 2004 Oct; 56(4):579-85. PubMed ID: 15295081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
